Clinical Trials Logo

Hormone Dependent Neoplasms clinical trials

View clinical trials related to Hormone Dependent Neoplasms.

Filter by:
  • None
  • Page 1

NCT ID: NCT04861896 Completed - Quality of Life Clinical Trials

A Research Study for Latina Women With Breast Cancer

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the feasibility and preliminary efficacy of a psychosocial eHealth intervention designed to improve hormone therapy adherence among Hispanic/Latinx women with breast cancer. Our proposed secondary outcomes are health-related quality of life and self-efficacy in managing hormone therapy side effects. The intervention components include breast cancer knowledge, hormone/endocrine therapy knowledge, stress awareness and management, social support, and enhanced communication and intimacy skills. The intervention will be delivered via a Smartphone application over a 12-week period. All participants will receive the intervention application (described below). Aside from using the Smartphone application for the recommended 12 weeks, participation in this study includes three assessments: baseline (at the beginning of the research study), 6-week follow-up, and 12-week follow-up.

NCT ID: NCT03849573 Completed - Breast Cancer Clinical Trials

A Web-Based Tool to Improve Breast Cancer Survivorship

Start date: May 29, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the efficacy of a psychosocial eHealth intervention on the proposed primary outcomes, hormone therapy adherence and health related quality of life (HRQoL), in breast cancer survivors. The intervention components include mindfulness-based stress reduction, breast cancer knowledge, stress awareness and management, social support, and enhanced communication. The intervention will be delivered via an online application over an 8-week period. Participants are randomized into either an intervention application (described above) or a control application (health information and general health promotion strategies). Aside from having access to the online application for the recommended 8 weeks with weekly online focus groups, participation in this study includes four assessments: baseline (at the beginning of the research study), post-intervention (8 weeks after baseline), a 6-month follow-up and a 12-month follow-up.

NCT ID: NCT03111615 Not yet recruiting - Clinical trials for Breast Cancer Female

HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer

HOTBreast
Start date: May 1, 2018
Phase: Phase 4
Study type: Interventional

Breast Cancer is a public health issue worldwide. The time from diagnosis to treatment initiation varies from country to country and regionally within a country. Early diagnosis and prompt treatment initiation are key factors in patient survival rates. Currently there is a rising trend, with a high percentage of patients with "Luminal" like breast cancer only undergoing adjuvant endocrine therapy. Authors argue that tumor biology alterations after introducing very early endocrine therapy might have a prognostic and therapeutic impact and should be studied.